Laniel, J.; Sultan, S.; Sinnett, D.; Laverdière, C.; Krajinovic, M.; Robaey, P.; Duong, L.; Lippé, S.
Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study. Cancers 2024, 16, 1208.
https://doi.org/10.3390/cancers16061208
AMA Style
Laniel J, Sultan S, Sinnett D, Laverdière C, Krajinovic M, Robaey P, Duong L, Lippé S.
Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study. Cancers. 2024; 16(6):1208.
https://doi.org/10.3390/cancers16061208
Chicago/Turabian Style
Laniel, Julie, Serge Sultan, Daniel Sinnett, Caroline Laverdière, Maja Krajinovic, Philippe Robaey, Luc Duong, and Sarah Lippé.
2024. "Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study" Cancers 16, no. 6: 1208.
https://doi.org/10.3390/cancers16061208
APA Style
Laniel, J., Sultan, S., Sinnett, D., Laverdière, C., Krajinovic, M., Robaey, P., Duong, L., & Lippé, S.
(2024). Cumulative Dosage of Intrathecal Chemotherapy Agents Predicts White Matter Integrity in Long-Term Survivors of Acute Lymphoblastic Leukemia: A PETALE Study. Cancers, 16(6), 1208.
https://doi.org/10.3390/cancers16061208
